Posts for the 'Antibiotics' Category
Ketek liver damage risk will lead to restrictions by FDA
According to an FDA advisory committee, the dangers of Ketek liver damage outweigh the potential benefits of the antibiotic when used to treat certain conditions. The committee has recommended that the manufacturer no longer be permitted to market the antibiotic for treatment of sinusitis or bronchitis, and that a stronger warning be required by the FDA. Read the rest of this entry »
FDA scientist questions the use of antibiotic Ketek
An FDA staff drug reviewer has openly criticized the continued use of the antibiotic Ketek in a letter to the New England Journal of Medicine published on November 23, 2006. Ketek side effects have included liver failure and death which the manufacturer did not adequately warn users about. Read the rest of this entry »
